<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-12-06" modified="2017-09-27" version="148">
<accession>Q8WU17</accession>
<accession>B3KMD5</accession>
<accession>O75485</accession>
<accession>Q7LDL3</accession>
<name>RN139_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase RNF139</fullName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>RING finger protein 139</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="20">RING-type E3 ubiquitin transferase RNF139</fullName>
</alternativeName>
<alternativeName>
<fullName>Translocation in renal carcinoma on chromosome 8 protein</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="24">RNF139</name>
<name type="synonym" evidence="21">TRC8</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1" evidence="20 21">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="9572" last="9577">
<title>The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.</title>
<authorList>
<person name="Gemmill R.M."/>
<person name="West J.D."/>
<person name="Boldog F."/>
<person name="Tanaka N."/>
<person name="Robinson L.J."/>
<person name="Smith D.I."/>
<person name="Li F."/>
<person name="Drabkin H.A."/>
</authorList>
<dbReference type="PubMed" id="9689122"/>
<dbReference type="DOI" id="10.1073/pnas.95.16.9572"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-60</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH FHIT</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4" evidence="22">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue evidence="22">Lung</tissue>
<tissue evidence="23">Pancreas</tissue>
</source>
</reference>
<reference key="5" evidence="20">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="11364" last="11369">
<title>RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination.</title>
<authorList>
<person name="Lorick K.L."/>
<person name="Jensen J.P."/>
<person name="Fang S."/>
<person name="Ong A.M."/>
<person name="Hatakeyama S."/>
<person name="Weissman A.M."/>
</authorList>
<dbReference type="PubMed" id="10500182"/>
<dbReference type="DOI" id="10.1073/pnas.96.20.11364"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="6" evidence="20">
<citation type="journal article" date="2002" name="Oncogene" volume="21" first="3507" last="3516">
<title>The TRC8 hereditary kidney cancer gene suppresses growth and functions with VHL in a common pathway.</title>
<authorList>
<person name="Gemmill R.M."/>
<person name="Bemis L.T."/>
<person name="Lee J.P."/>
<person name="Sozen M.A."/>
<person name="Baron A."/>
<person name="Zeng C."/>
<person name="Erickson P.F."/>
<person name="Hooper J.E."/>
<person name="Drabkin H.A."/>
</authorList>
<dbReference type="PubMed" id="12032852"/>
<dbReference type="DOI" id="10.1038/sj.onc.1205437"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH VHL</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="2263" last="2271">
<title>RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene.</title>
<authorList>
<person name="Brauweiler A."/>
<person name="Lorick K.L."/>
<person name="Lee J.P."/>
<person name="Tsai Y.C."/>
<person name="Chan D."/>
<person name="Weissman A.M."/>
<person name="Drabkin H.A."/>
<person name="Gemmill R.M."/>
</authorList>
<dbReference type="PubMed" id="17016439"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210017"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 547-CYS--CYS-550; 547-CYS--HIS-586; 557-SER--ARG-559; 572-LEU--LYS-574 AND 582-CYS--CYS-585</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28995" last="29004">
<title>The sterol-sensing endoplasmic reticulum (ER) membrane protein TRC8 hampers ER to Golgi transport of sterol regulatory element-binding protein-2 (SREBP-2)/SREBP cleavage-activated protein and reduces SREBP-2 cleavage.</title>
<authorList>
<person name="Irisawa M."/>
<person name="Inoue J."/>
<person name="Ozawa N."/>
<person name="Mori K."/>
<person name="Sato R."/>
</authorList>
<dbReference type="PubMed" id="19706601"/>
<dbReference type="DOI" id="10.1074/jbc.M109.041376"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SREBF2; SCAP AND SEC24B</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF 547-CYS--CYS-550 AND 547-CYS--HIS-586</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Cell Biol." volume="186" first="685" last="692">
<title>The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER.</title>
<authorList>
<person name="Stagg H.R."/>
<person name="Thomas M."/>
<person name="van den Boomen D."/>
<person name="Wiertz E.J."/>
<person name="Drabkin H.A."/>
<person name="Gemmill R.M."/>
<person name="Lehner P.J."/>
</authorList>
<dbReference type="PubMed" id="19720873"/>
<dbReference type="DOI" id="10.1083/jcb.200906110"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MHC CLASS I AND HM13</scope>
<scope>MUTAGENESIS OF 547-CYS--CYS-550 AND 547-CYS--HIS-586</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="93" last="106">
<title>The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways.</title>
<authorList>
<person name="Lee J.P."/>
<person name="Brauweiler A."/>
<person name="Rudolph M."/>
<person name="Hooper J.E."/>
<person name="Drabkin H.A."/>
<person name="Gemmill R.M."/>
</authorList>
<dbReference type="PubMed" id="20068067"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-08-0491"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INSIG1; INSIG2; EIF3F AND EIF3H</scope>
<scope>INDUCTION</scope>
<scope>MUTAGENESIS OF 547-CYS--CYS-550 AND 547-CYS--HIS-586</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-663</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="EMBO J." volume="33" first="2492" last="2506">
<title>Signal peptide peptidase functions in ERAD to cleave the unfolded protein response regulator XBP1u.</title>
<authorList>
<person name="Chen C.Y."/>
<person name="Malchus N.S."/>
<person name="Hehn B."/>
<person name="Stelzer W."/>
<person name="Avci D."/>
<person name="Langosch D."/>
<person name="Lemberg M.K."/>
</authorList>
<dbReference type="PubMed" id="25239945"/>
<dbReference type="DOI" id="10.15252/embj.201488208"/>
</citation>
<scope>INTERACTION WITH HM13 AND XBP1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-634 AND THR-635</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<comment type="function">
<text evidence="12 13 14 15 16 17">E3-ubiquitin ligase; acts as a negative regulator of the cell proliferation through mechanisms involving G2/M arrest and cell death. Required for MHC class I ubiquitination in cells expressing the cytomegalovirus protein US2 before dislocation from the endoplasmic reticulum (ER). Affects SREBP processing by hindering the SREBP/SCAP complex translocation from the ER to the Golgi, thereby reducing SREBF2 target gene expression. Required for INSIG1 ubiquitination. May be required for EIF3 complex ubiquitination. May function as a signaling receptor.</text>
</comment>
<comment type="catalytic activity">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="13 15 16 17 18">Interacts with MHC class I and HM13 (PubMed:19720873, PubMed:25239945). Interacts with VHL. Component of SCAP/SREBP complex composed of SREBF2, SCAP and RNF139; the complex hampers the interaction between SCAP and SEC24B, thereby reducing SREBF2 proteolytic processing. Interacts with SREBF2 (via C-terminal domain). Interacts with SCAP; the interaction inhibits the interaction of SCAP with SEC24B and hampering the ER to Golgi transport of the SCAP/SREBP complex. Interacts with SEC24B. Interacts with INSIG1 and INSIG2. Interacts with EIF3F and EIF3H; the interaction leads to protein translation inhibitions in a ubiquitination-dependent manner (PubMed:12032852, PubMed:19706601, PubMed:20068067). Interacts with XBP1 isoform 1; the interaction induces ubiquitination and degradation of XBP1 isoform 1 (PubMed:25239945).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1551681"/>
<interactant intactId="EBI-347472">
<id>Q8TCT9</id>
<label>HM13</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1551681"/>
<interactant intactId="EBI-301246">
<id>P40337</id>
<label>VHL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13">Endoplasmic reticulum membrane</location>
<topology evidence="13">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="19">Highly expressed in testis, placenta and adrenal gland. Moderate expression in heart, brain, liver, skeletal muscle and pancreas, and low expression in lung and kidney.</text>
</comment>
<comment type="induction">
<text evidence="17">Down-regulated by sterols (at protein level).</text>
</comment>
<comment type="domain">
<text>The RING-type zinc finger domain mediates ubiquitin ligase activity.</text>
</comment>
<comment type="PTM">
<text evidence="15">Autoubiquitinated. Ubiquitination is induced by sterol and leads to ist degradation via the ubiquitin-proteasome pathway.</text>
</comment>
<comment type="disease">
<disease id="DI-02254">
<name>Renal cell carcinoma</name>
<acronym>RCC</acronym>
<description>Renal cell carcinoma is a heterogeneous group of sporadic or hereditary carcinoma derived from cells of the proximal renal tubular epithelium. It is subclassified into clear cell renal carcinoma (non-papillary carcinoma), papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma with medullary carcinoma of the kidney, and unclassified renal cell carcinoma. Clear cell renal cell carcinoma is the most common subtype.</description>
<dbReference type="MIM" id="144700"/>
</disease>
<text>The disease may be caused by mutations affecting the gene represented in this entry. A chromosomal aberration involving RNF139 has been found in a lymphoblastoid cell line established from a family with renal cell carcinoma and thyroid carcinoma. Translocation (3;8)(q14.2;q24.1) with FHIT. RNF139 is found to be fused to FHIT and disrupted within the sterol-sensing domain. In contrast, the FHIT coding region is maintained and expressed. Sporadic cases of renal carcinoma, where an acquired mutation in RNF139 results in the duplication of 12 nucleotides in the 5'-UTR, has also been identified.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/TRC8ID500.html"/>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="AF064800">
<property type="protein sequence ID" value="AAC39931.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF064801">
<property type="protein sequence ID" value="AAC39930.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK001602">
<property type="protein sequence ID" value="BAG50947.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471060">
<property type="protein sequence ID" value="EAW92064.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021571">
<property type="protein sequence ID" value="AAH21571.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC064636">
<property type="protein sequence ID" value="AAH64636.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6350.1"/>
<dbReference type="RefSeq" id="NP_009149.2">
<property type="nucleotide sequence ID" value="NM_007218.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.744151"/>
<dbReference type="ProteinModelPortal" id="Q8WU17"/>
<dbReference type="SMR" id="Q8WU17"/>
<dbReference type="BioGrid" id="116401">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="IntAct" id="Q8WU17">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000304051"/>
<dbReference type="iPTMnet" id="Q8WU17"/>
<dbReference type="PhosphoSitePlus" id="Q8WU17"/>
<dbReference type="BioMuta" id="RNF139"/>
<dbReference type="DMDM" id="74760542"/>
<dbReference type="EPD" id="Q8WU17"/>
<dbReference type="MaxQB" id="Q8WU17"/>
<dbReference type="PaxDb" id="Q8WU17"/>
<dbReference type="PeptideAtlas" id="Q8WU17"/>
<dbReference type="PRIDE" id="Q8WU17"/>
<dbReference type="Ensembl" id="ENST00000303545">
<property type="protein sequence ID" value="ENSP00000304051"/>
<property type="gene ID" value="ENSG00000170881"/>
</dbReference>
<dbReference type="GeneID" id="11236"/>
<dbReference type="KEGG" id="hsa:11236"/>
<dbReference type="UCSC" id="uc003yrc.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="11236"/>
<dbReference type="DisGeNET" id="11236"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000170881.4"/>
<dbReference type="GeneCards" id="RNF139"/>
<dbReference type="HGNC" id="HGNC:17023">
<property type="gene designation" value="RNF139"/>
</dbReference>
<dbReference type="HPA" id="HPA001202"/>
<dbReference type="MalaCards" id="RNF139"/>
<dbReference type="MIM" id="144700">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603046">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8WU17"/>
<dbReference type="OpenTargets" id="ENSG00000170881"/>
<dbReference type="Orphanet" id="151">
<property type="disease" value="Familial renal cell carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134945850"/>
<dbReference type="eggNOG" id="KOG0802">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5243">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000062938"/>
<dbReference type="HOGENOM" id="HOG000267029"/>
<dbReference type="HOVERGEN" id="HBG053146"/>
<dbReference type="InParanoid" id="Q8WU17"/>
<dbReference type="KO" id="K15703"/>
<dbReference type="OMA" id="RIRFPDI"/>
<dbReference type="OrthoDB" id="EOG091G020N"/>
<dbReference type="PhylomeDB" id="Q8WU17"/>
<dbReference type="TreeFam" id="TF318635"/>
<dbReference type="Reactome" id="R-HSA-901032">
<property type="pathway name" value="ER Quality Control Compartment (ERQC)"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="GeneWiki" id="RNF139"/>
<dbReference type="GenomeRNAi" id="11236"/>
<dbReference type="PRO" id="PR:Q8WU17"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000170881"/>
<dbReference type="CleanEx" id="HS_RNF139"/>
<dbReference type="ExpressionAtlas" id="Q8WU17">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8WU17">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0036513">
<property type="term" value="C:Derlin-1 retrotranslocation complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0044322">
<property type="term" value="C:endoplasmic reticulum quality control compartment"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016874">
<property type="term" value="F:ligase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002020">
<property type="term" value="F:protease binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004872">
<property type="term" value="F:receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1904264">
<property type="term" value="F:ubiquitin protein ligase activity involved in ERAD pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019787">
<property type="term" value="F:ubiquitin-like protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1904380">
<property type="term" value="P:endoplasmic reticulum mannose trimming"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0036503">
<property type="term" value="P:ERAD pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000060">
<property type="term" value="P:positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031648">
<property type="term" value="P:protein destabilization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000209">
<property type="term" value="P:protein polyubiquitination"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016567">
<property type="term" value="P:protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060628">
<property type="term" value="P:regulation of ER to Golgi vesicle-mediated transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070613">
<property type="term" value="P:regulation of protein processing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031396">
<property type="term" value="P:regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR025754">
<property type="entry name" value="TRC8_N_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR011016">
<property type="entry name" value="Znf_RING-CH"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="Pfam" id="PF13705">
<property type="entry name" value="TRC8_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13639">
<property type="entry name" value="zf-RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00744">
<property type="entry name" value="RINGv"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="initiator methionine" description="Removed" evidence="7">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="E3 ubiquitin-protein ligase RNF139" id="PRO_0000056098">
<location>
<begin position="2"/>
<end position="664"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="51"/>
<end position="71"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="85"/>
<end position="105"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="125"/>
<end position="145"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="154"/>
<end position="174"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="178"/>
<end position="198"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="293"/>
<end position="313"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="323"/>
<end position="343"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="356"/>
<end position="376"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="390"/>
<end position="410"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="420"/>
<end position="440"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="469"/>
<end position="489"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="10">
<location>
<begin position="495"/>
<end position="512"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type; atypical" evidence="11">
<location>
<begin position="547"/>
<end position="586"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="7">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="634"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="9">
<location>
<position position="635"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="1 2 3 4 5 6 8">
<location>
<position position="663"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increases proliferation. Rescues MHC class I to the cell surface. Fails to down-regulate SREBF1 and SREBF2." evidence="14 15 16 17">
<location>
<begin position="547"/>
<end position="586"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination activity. Increases proliferation. Does not phosphorylates CHEK2 on T-68. Does not phosphorylates ATM on S-1981. Rescues MHC class I to the cell surface. Suppresses SREBF2 processing in the presence or absence of sterols. Fails to down-regulate SREBF1 and SREBF2. Decreases INSIG1 ubiquitination." evidence="14 15 16 17">
<original>CAIC</original>
<variation>SAIS</variation>
<location>
<begin position="547"/>
<end position="550"/>
</location>
</feature>
<feature type="mutagenesis site" description="Retaines about 30% of ubiquitination activity." evidence="14">
<original>SAR</original>
<variation>AAA</variation>
<location>
<begin position="557"/>
<end position="559"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination activity. Increases proliferation." evidence="14">
<original>LRK</original>
<variation>AAA</variation>
<location>
<begin position="572"/>
<end position="574"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination activity. Increases proliferation." evidence="14">
<original>CPMC</original>
<variation>APMA</variation>
<location>
<begin position="582"/>
<end position="585"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC39930/AAC39931." ref="1" evidence="20">
<original>V</original>
<variation>I</variation>
<location>
<position position="18"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10500182"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12032852"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17016439"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19706601"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19720873"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20068067"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25239945"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9689122"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000305"/>
<evidence key="21" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAC39930.1"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAH21571.1"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000312">
<source>
<dbReference type="EMBL" id="AAH64636.1"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:17023"/>
</source>
</evidence>
<sequence length="664" mass="75994" checksum="9885F5915F019EF5" modified="2002-03-01" version="1">
MAAVGPPQQQVRMAHQQVWAALEVALRVPCLYIIDAIFNSYPDSSQSRFCIVLQIFLRLF
GVFASSIVLILSQRSLFKFYTYSSAFLLAATSVLVNYYASLHIDFYGAYNTSAFGIELLP
RKGPSLWMALIVLQLTFGIGYVTLLQIHSIYSQLIILDLLVPVIGLITELPLHIRETLLF
TSSLILTLNTVFVLAVKLKWFYYSTRYVYLLVRHMYRIYGLQLLMEDTWKRIRFPDILRV
FWLTRVTAQATVLMYILRMANETDSFFISWDDFWDLICNLIISGCDSTLTVLGMSAVISS
VAHYLGLGILAFIGSTEEDDRRLGFVAPVLFFILALQTGLSGLRPEERLIRLSRNMCLLL
TAVLHFIHGMTDPVLMSLSASHVSSFRRHFPVLFVSACLFILPVLLSYVLWHHYALNTWL
FAVTAFCVELCLKVIVSLTVYTLFMIDGYYNVLWEKLDDYVYYVRSTGSIIEFIFGVVMF
GNGAYTMMFESGSKIRAFMMCLHAYFNIYLQAKNGWKTFMNRRTAVKKINSLPEIKGSRL
QEINDVCAICYHEFTTSARITPCNHYFHALCLRKWLYIQDTCPMCHQKVYIEDDIKDNSN
VSNNNGFIPPNETPEEAVREAAAESDRELNEDDSTDCDDDVQRERNGVIQHTGAAAEEFN
DDTD
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>